Mayo Clinic, Thermo Fisher Launch Precure for Early Signs AI
Rochester, Minnesota, and Waltham, Massachusetts, U.S., September 15, 2026 Mayo Clinic and Thermo Fisher Scientific have launched Precure, LLC,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Rochester, Minnesota, and Waltham, Massachusetts, U.S., September 15, 2026 Mayo Clinic and Thermo Fisher Scientific have launched Precure, LLC,...
Boston, Massachusetts, U.S., September 15, 2026 Xylo Bio, a clinical-stage biotechnology company developing novel neurotherapeutics for psychiatric and neurological...
Irvine, California, U.S., September 15, 2026 Allergan Aesthetics, an AbbVie company, is preparing to advance scientific discussion around skin...
